Angiotensin II regulates islet microcirculation and insulin secretion in mice

Microcirculation

Volumn 21, Issue 2, 2014, Pages 112-123

  Ihoriya, Chieko ^a   Satoh, Minoru ^a   Kuwabara, Atsunori ^a   Sasaki, Tamaki ^a   Kashihara, Naoki ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Angiotensin II; Angiotensin type 1 receptor blocker; in vivo imaging; Insulin secretion; Islet; Microcirculation

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; INSULIN; VASOCONSTRICTOR AGENT;

ANIMAL; DRUG EFFECTS; MALE; MOUSE; PANCREAS ISLET; SECRETION (PROCESS); TRANSGENIC MOUSE; VASCULARIZATION; VASOCONSTRICTION;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; INSULIN; ISLETS OF LANGERHANS; MALE; MICE; MICE, TRANSGENIC; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 84894027241     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1111/micc.12094     Document Type: Article

References (41)

1. Anneren C, Welsh M, Jansson L. Glucose intolerance and reduced islet blood flow in transgenic mice expressing the FRK tyrosine kinase under the control of the rat insulin promoter. Am J Physiol Endocrinol Metab 292: E1183-E1190, 2007.
2. Ballian N, Brunicardi FC. Islet vasculature as a regulator of endocrine pancreas function. World J Surg 31: 705-714, 2007.
3. Bonner-Weir S, Orci L. New perspectives on the microvasculature of the islets of Langerhans in the rat. Diabetes 31: 883-889, 1982.
4. Carlsson PO, Berne C, Jansson L. Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats. Diabetologia 41: 127-133, 1998.
5. Chai W, Wang W, Liu J, Barrett EJ, Carey RM, Cao W, Liu Z. Angiotensin II type 1 and type 2 receptors regulate basal skeletal muscle microvascular volume and glucose use. Hypertension 55: 523-530, 2010.
6. Chappell MC, Millsted A, Diz DI, Brosnihan KB, Ferrario CM. Evidence for an intrinsic angiotensin system in the canine pancreas. J Hypertens 9: 751-759, 1991.
7. Chu KY, Lau T, Carlsson PO, Leung PS. Angiotensin II type 1 receptor blockade improves beta-cell function and glucose tolerance in a mouse model of type 2 diabetes. Diabetes 55: 367-374, 2006.
8. Conen D, Ridker PM, Mora S, Buring JE, Glynn RJ. Blood pressure and risk of developing type 2 diabetes mellitus: the Women's Health Study. Eur Heart J 28: 2937-2943, 2007.
9. Dunning BE, Taborsky GJ, Jr. Neural control of islet function by norepinephrine and sympathetic neuropeptides. Adv Exp Med Biol 291: 107-127, 1991.
10. Durham HA, Truett GE. Development of insulin resistance and hyperphagia in Zucker fatty rats. Am J Physiol Regul Integr Comp Physiol 290: R652-R658, 2006.
11. Eberhard D, Kragl M, Lammert E. 'Giving and taking': endothelial and beta-cells in the islets of Langerhans. Trends Endocrinol Metab 21: 457-463, 2010.
12. Elliott WJ, Meyer PM. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet 369: 201-207, 2007.
13. Folli F, Kahn CR, Hansen H, Bouchie JL, Feener EP. Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk. J Clin Invest 100: 2158-2169, 1997.
14. Fujimoto S, Satoh M, Nagasu H, Horike H, Sasaki T, Kashihara N. Azelnidipine exerts renoprotective effects by improvement of renal microcirculation in angiotensin II infusion rats. Nephrol Dial Transplant 24: 3651-3658, 2009.
15. Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. N Engl J Med 342: 905-912, 2000.
16. Hara M, Dizon RF, Glick BS, Lee CS, Kaestner KH, Piston DW, Bindokas VP. Imaging pancreatic beta-cells in the intact pancreas. Am J Physiol Endocrinol Metab 290: E1041-E1047, 2006.
17. Hayden MR, Sowers JR. Treating hypertension while protecting the vulnerable islet in the cardiometabolic syndrome. J Am Soc Hypertens 2: 239-266, 2008.
18. Huang Z, Jansson L, Sjoholm A. Pancreatic islet blood flow is selectively enhanced by captopril, irbesartan and pravastatin, and suppressed by palmitate. Biochem Biophys Res Commun 346: 26-32, 2006.
19. Huang Z, Jansson L, Sjoholm A. Vasoactive drugs enhance pancreatic islet blood flow, augment insulin secretion and improve glucose tolerance in female rats. Clin Sci (Lond) 112: 69-76, 2007.
20. Iwase M, Tashiro K, Uchizono Y, Goto D, Yoshinari M. Pancreatic islet blood flow in conscious rats during hyperglycemia and hypoglycemia. Am J Physiol Regul Integr Comp Physiol 280: R1601-R1605, 2001.
21. Iwase M, Uchizono Y, Tashiro K, Goto D, Iida M. Islet hyperperfusion during prediabetic phase in OLETF rats, a model of type 2 diabetes. Diabetes 51: 2530-2535, 2002.
22. Iwashita N, Uchida T, Choi JB, Azuma K, Ogihara T, Ferrara N, Gerber H, Kawamori R, Inoue M, Watada H. Impaired insulin secretion in vivo but enhanced insulin secretion from isolated islets in pancreatic beta cell-specific vascular endothelial growth factor-A knock-out mice. Diabetologia 50: 380-389, 2007.
23. Jansson L. The regulation of pancreatic islet blood flow. Diabetes Metab Rev 10: 407-416, 1994.
24. Juan CC, Chien Y, Wu LY, Yang WM, Chang CL, Lai YH, Ho PH, Kwok CF, Ho LT. Angiotensin II enhances insulin sensitivity in vitro and in vivo. Endocrinology 146: 2246-2254, 2005.
25. Kampf C, Lau T, Olsson R, Leung PS, Carlsson PO. Angiotensin II type 1 receptor inhibition markedly improves the blood perfusion, oxygen tension and first phase of glucose-stimulated insulin secretion in revascularised syngeneic mouse islet grafts. Diabetologia 48: 1159-1167, 2005.
26. Kuwabara A, Satoh M, Tomita N, Sasaki T, Kashihara N. Deterioration of glomerular endothelial surface layer induced by oxidative stress is implicated in altered permeability of macromolecules in Zucker fatty rats. Diabetologia 53: 2056-2065, 2010.
27. Lai EY, Jansson L, Patzak A, Persson AE. Vascular reactivity in arterioles from normal and alloxan-diabetic mice: studies on single perfused islets. Diabetes 56: 107-112, 2007.
28. Lai EY, Persson AE, Bodin B, Kallskog O, Andersson A, Pettersson U, Hansell P, Jansson L. Endothelin-1 and pancreatic islet vasculature: studies in vivo and on isolated, vascularly perfused pancreatic islets. Am J Physiol Endocrinol Metab 292: E1616-E1623, 2007.
29. Lau T, Carlsson PO, Leung PS. Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets. Diabetologia 47: 240-248, 2004.
30. Leung PS, Chan HC, Fu LX, Wong PY. Localization of angiotensin II receptor subtypes AT1 and AT2 in the pancreas of rodents. J Endocrinol 153: 269-274, 1997.
31. Leung KK, Leung PS. Effects of hyperglycemia on angiotensin II receptor type 1 expression and insulin secretion in an INS-1E pancreatic beta-cell line. JOP 9: 290-299, 2008.
32. Olsson R, Carlsson PO. The pancreatic islet endothelial cell: emerging roles in islet function and disease. Int J Biochem Cell Biol 38: 710-714, 2006.
33. Olsson R, Carlsson PO. A low-oxygenated subpopulation of pancreatic islets constitutes a functional reserve of endocrine cells. Diabetes 60: 2068-2075, 2011.
34. Paul M, Poyan Mehr A, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 86: 747-803, 2006.
35. Rasband WS. ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA, http://rsb.info.nih.gov/ij/, 1997-2012.
36. Satoh M, Kobayashi S, Kuwabara A, Tomita N, Sasaki T, Kashihara N. In vivo visualization of glomerular microcirculation and hyperfiltration in streptozotocin-induced diabetic rats. Microcirculation 17: 103-112, 2010.
37. Satoh M, Nagasu H, Haruna Y, Ihoriya C, Kadoya H, Sasaki T, Kashihara N. Hypertension promotes islet morphological changes with vascular injury on pre-diabetic status in SHRsp rats. Clin Exp Hypertens. 2013, doi:10.3109/10641963.2013.804539.
38. Satoh M, Ogita H, Takeshita K, Mukai Y, Kwiatkowski DJ, Liao JK. Requirement of Rac1 in the development of cardiac hypertrophy. Proc Natl Acad Sci U S A 103: 7432-7437, 2006.
39. Schaeffer M, Hodson DJ, Lafont C, Mollard P. Endocrine cells and blood vessels work in tandem to generate hormone pulses. J Mol Endocrinol 47: R59-R66, 2011.
40. Vikman J, Jimenez-Feltstrom J, Nyman P, Thelin J, Eliasson L. Insulin secretion is highly sensitive to desorption of plasma membrane cholesterol. FASEB J 23: 58-67, 2009.
41. Yoshioka M, Kayo T, Ikeda T, Koizumi A. A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes 46: 887-894, 1997.